Viscum album L. preparation Isorel modifies the immune response in normal and in tumour-bearing mice

Anti-Cancer Drugs

Volumn 8, Issue SUPPL. 1, 1997, Pages

  Jurin, M ^a   Zarkovic, N ^a   Borovic, S ^a   Kissel, D ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b Johanneshaus   (Germany)

Author keywords

Immunomodulation; Mistletoe; Mouse fibrosarcoma; Plaque forming cells; Skin grafting; Viscum album

Indexed keywords

3 METHYLCHOLANTHRENE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; GRAFT SURVIVAL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; SHEEP ERYTHROCYTE; SKIN GRAFT; SURVIVAL TIME; VISCUM ALBUM;

VISCUM ALBUM;

EID: 0031009208     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199704001-00007     Document Type: Conference Paper

References (24)

1. Khwaja TA, Dias CB, Pentecst S: Resent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids. Oncology 1986, 43(suppl 1): 16-22.
2. Salzer G, Havelec L: Prevention of relapse in operated bronchial carcinoma patients with the mistletoe preparation Iscador, report on clinical trials for the period 1969-1971 [in German] Onkologie 1978, 1: 264-267.
3. Evans MR, Preece AW: Viscum album: a possible treatment for cancer? Bristol Med Chir J 1973, 88: 17-20.
4. Kjaer MN: Mistletoe (Iscador) therapy in stage IV renal adenocarcinoma. A phase II study in patients with measurable lung metastases. Acta Oncol 1989, 28: 424-489.
5. Parrado A, Casares S, Rodriguez-Fernandez JM: Lymphokine-activated killer cytotoxicily and lymphocyte subpopulation in patients with acute leukemia. Leuk Res 1994, 18: 815-822.
6. Franz H: Request for an impartial discussion of the so-called mistletoe therapy. Oncology 1986, 43 (suppl 1): 1.
7. Wagner H, Jordan F, Feil B: Studies on the standardization of mistletoe preparation. Oncology 1986, 43 (suppl 1): 16-22.
8. Bloksma N, van Dijk H, Korst P, Willers JM: Cellular and humoral adjuvant activity of mistletoe extract. Immunobiology 1979, 156: 309-319.
9. Khwaja TA, Dias CB, Pentecost S, Papoian H: Studies on cytotoxic and immunologic effects of Viscum album (mistletoe). Proc Am Assoc Cancer Res 1981, 22: 153-162.
10. Hostanska K, Hajto T, Spagnoli GC, Fischer J, Lentzen H, Herrmann R: A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells. Nat Immun 1995, 14: 295-304.
11. Jurin M, Zarkovic N, Hrzenjak M, Ilic Z: Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel. Oncology 1993, 50: 393-398.
12. Kissel D, Jurin M, Zarkovic N: Cytostatic and immunomodulating effects of Viscum album [in German] Erfahrungsheilkunde 1990, 39: 59-66.
13. Jurin M, Zarkovic N, Borovic S, Kissel D: Immunomodulation by the Viscum album L. preparation Isorel and its antitumorous effects. In: Grundlagen der Misteltherapic - Aktueller Stand der Forschung und klinische Anwendung. Edited by Scheer R, Becker H, Berg PA, Stuttgart: Hippokrates Verlag. 1996:315-324.
14. Zarkovic N, Trbojevic-Cepe M, Ilic Z, Hrzenjak M, Grainca S, Jurin M: Comparison of the effects of high and low concentration of the separated Viscum album L. lectins and of the plain mistletoe plant preparation (Isorel) on the growth of normal and tumor cells in vitro. Period Biol 1995, 97: 61-67.
15. Hajto T, Hostanska K, Vehmeyer K, Gabius HJ: Immunostimulatory effects by mistletoe lectin. In: Lectins and Glycoconjugates in Oncology. Edited by Gabius H, Nagel GA, Berlin: Springer, 1998:199-206.
16. Beuth J, Stoffel B, Ko HL, Buss B, Tunggal L, Pulverer G: Immunostimulating activity of different dosages of mistletoe lectin-1 in patients with mammary carcinoma. Arzneim Forsch Drug Res 1995, 45: 505-507.
17. Jacob J, Kelsoe G: In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J Exp Med 1992, 176: 679-687.
18. Cyster JG, Hartley SB, Goodnow CC: Competition for follicular niches excluded self-reactive cells from the recirculating B-cell repertoire. Nature 1994, 371: 389-395.
19. Kelsoe G: Life and death in germinal centers (redux). Immunity 1990, 4: 107-111.
20. Jenkins MK: The ups and downs off cell costimulation. Immunity 1994, 1: 443-446.
21. Rothstein TL: Signals and susceptibility to programmed death in B cells. Curr Opin Immunol 1996, 8: 362-371.
22. Swain SL, Cambier JC: Orchestration of the immune response: multilevel regulation of diverse regulatory processes. Curr Opin Immunol 1996, 8: 309-311.
23. Lane P: Development of B-cell memory and effector function. Curr Cpin Immunol 1996, 8: 331-335.
24. McHeyzer-Williams MG: Visualizing immune response in vivo. Curr Opin Immunol 1996, 8: 321-326.